Selected Growth Track partners are:
• OKKO Health (United Kingdom): OKKO Health has developed a personalized smartphone software for accurate remote monitoring of visual health outside of ophthalmology clinics.
• Wellthy Theapeutics (India): Wellthy Therapeutics has a clinically validated behavioral intervention platform to help people change their behaviors and reduce their risk of chronic disease.
• Litesprite (USA): Litesprite creates games that combine medical treatment and engagement of mobile gaming to help patients proactively manage chronic health conditions such as stress, anxiety and depression.
• Visotec (Germany): At-home hand-held optical coherence tomography (OCT) for monitoring.
• BioLum Sciences (United States): Developer of the BioSense AMD – a point-of-care, low cost device that works with a proprietary biomarker technology to analyze airway inflammation.
• Upside Health: Upside Health has developed Ouchie, an app for chronic pain management through tools such as congnitive behavioral therapy, community support, pain tracking, education resources and integration with clinicians.
About G4A
Bayer is combining the Group’s digital health initiatives under the name G4A (formerly Grants4Apps). In addition to identifying new technologies, business models, and market trends, these initiatives also involve collaborating with start-ups. Since its launch in 2013, Bayer has supported over 150 digital health companies. This has resulted in more than 30 direct collaborations with digital health companies. Bayer now operates G4A in more than 13 countries, developing and promoting collaborative health care projects around the world.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros.
Back to HCB News
